Om

China Pharma Holdings Inc. is a pharmaceutical company focused on the development, manufacture, and marketing of drugs and healthcare products in China. Through its wholly owned subsidiary, Hainan Helpson Medicine & Biotechnique Co., Ltd., the company operates an integrated business covering research and development, production, and sales. Its portfolio includes products for cardiovascular, central nervous system, infectious, respiratory, and digestive diseases, along with comprehensive healthcare and protective products. China Pharma Holdings Inc. works primarily with dosage forms such as injectables, tablets, capsules, and oral solutions, serving hospitals, retailers, and other healthcare channels. The company is based in Haikou, Hainan, and plays a specialized role in supplying medicines aimed at conditions with significant prevalence in the Chinese market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CHINA PHARMA HOLDINGS MED ENDAVU: Køb China Pharma Holdings ($CPHI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i China Pharma Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.